TVTX Stock Analysis: Buy, Sell, or Hold?
TVTX - Travere Therapeutics, Inc. Common Stock
$55.89
-1.39 (-2.43%)
▼
5d:
-2.56%
30d:
-0.8%
90d:
+32.69%
BUY
MODERATE Confidence
Analysis Updated: Jul 31, 2026 12:00 AM ET
Earnings: Aug 04, 2026
TODAY
Smart Money Accumulation
None View Scanner →
Strength: 6.7/10
Get Alerted When TVTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
💡 BUY OPPORTUNITY: TVTX shows positive signals but monitor for confirmation. Market pricing in 0.5% decline. Moderate conviction.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$110.52
Based on 14.5% avg growth
INTRINSIC VALUE TODAY
$68.63
18.6% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 11.9x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: TVTX is currently trading at $55.89, which is considered slightly low relative to its 30-day fair value range of $55.84 to $57.92. The stock's valuation (Forward PE: 11.7) is in line with its historical norms (11.9). Remarkably, the market is currently pricing in an annual earnings decline of 0.5% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, TVTX is in a strong uptrend. The price is currently testing key support at $54.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, TVTX is in a strong uptrend. The price is currently testing key support at $54.32. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$55.84 -
$57.92
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.8%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- NEUTRAL: Near Wall St target ($59.14)
Trading Range Analysis
30-Day Trading Range
$55.84 -
$57.92
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$54.32
Resistance Level
$60.00
Current Trend
Strong Uptrend
Technical data as of
Jul 31, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.72
Wall Street Target
$59.14
(+5.8%)
Revenue Growth (YoY)
55.6%
Profit Margin
-4.0%
Valuation Discount vs History
-0.5% cheaper
PE vs Historical
11.7 vs 11.9
FAIR
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-0.5%
(market-implied from PE analysis)
1-Year Target
$55.61
(-1%)
2-Year Target
$55.33
(-1%)
3-Year Target
$55.06
(-2%)
3-Yr Target (if PE normalizes)
(PE: 12→12)
$55.91
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 20.7, Growth: 154.1%)
$333.69
(+497%)
Base:
(SPY PE: 11.7, Growth: 154.1%)
$188.63
(+238%)
Bear:
(PE: 10.0, Growth: 154.1%)
$160.33
(+187%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.7 to 11.9
Stabilization Target:
$56.76
(+1.5%)
PE Expansion Potential:
+1.5%
Share & Embed Analysis
Last updated: August 03, 2026 2:32 AM ET
Data refreshes hourly during market hours. Next update: 3:32 AM
Data refreshes hourly during market hours. Next update: 3:32 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is TVTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
17
Sells
Net
INSIDERS SELLING
Recent Transactions
William E Rote
SELL
9100 shares
2026-04-22
Christopher R Cline
SELL
1014 shares
2026-04-15
Elizabeth E Reed
SELL
6785 shares
2026-04-15
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$22 | 49 HOLD |
|
ARGX
argenx NV ADR |
STRONG BUY
22 analysts |
$1080 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$52 | 54 HOLD |
|
KYMR
Kymera Therapeutics Inc |
STRONG BUY
20 analysts |
$127 | 59 HOLD |
|
MRUS
Merus BV |
STRONG BUY
17 analysts |
$97 | 55 HOLD |
Advanced TVTX Option Strategies
Professional options setups generated by AI based on today's TVTX price and gamma walls.
